Oxford Capital is a UK-based venture capital firm founded in 1999 that invests from pre-seed to growth in technology and science companies. It manages early-stage ('Backing Founders') and growth-stage ('Backing Growth') funds and has deployed over £500 million to date.
Deal activity increased 200% year-over-year (3 deals in the last 12 months). Average disclosed round size is $26.4M (across 33 rounds with reported amounts).
Portfolio
47
Fund Size
—
Top Stage
Seed
Last 12 Mo
3
Team
David Mott
Founder Partner
Adrian Christofides
Director of Capital Formation
Adriana Obloj
Director, Finance & Operations
David Van Oss
Non-Executive Director
James Witter
Non-Executive Director
Leo Castellanos
Investment Director
Stephen Hampson
Investment Director
Millie Feeney
Associate, Investor Relations
Nick Sudlow
Senior Manager, Investor Relations
Antony Shaw
Senior Manager, Operations
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| NNoggin HQ | Seed | — | Aug 2026 |
| Series C | — | Jun 2026 | |
| Series A | — | Apr 2026 | |
| Series C | — | Jan 2026 | |
| Growth | $130M | Jan 2026 | |
| Series C | $90M | Jan 2026 | |
| Pre-Seed | — | Jan 2025 | |
| Series A | $30M | Jan 2025 | |
| NNoggin HQ | Pre-Seed | — | Apr 2024 |
| Seed | $1.4M | Apr 2024 | |
| Series C | $100M | Nov 2023 | |
| MMachine Discovery | Seed | — | Sep 2023 |
| Series B | $20M | Mar 2023 | |
| Seed | $3.6M | Mar 2023 | |
| OOxford Cancer Analytics (OXcan) | Seed | — | Jan 2023 |
| Series A | $12M | Jan 2023 | |
| Seed | — | Jan 2023 | |
| Series C | — | Sep 2022 | |
| Series B | — | Jun 2022 | |
| Unknown | — | Mar 2022 | |
| Series B | $54M | Jan 2022 | |
| Series A | $11M | Jan 2022 | |
| Series B | $54M | Jan 2022 | |
| Series D | — | Jan 2022 | |
| Series A | $145M | Jan 2022 |
Top Co-Investors
Last updated: 20 October 2026
